HomeACQUISITIONS and MERGERS

ACQUISITIONS and MERGERS

Medtronic Expands ENT Porfolio: Receives FDA Clearance of NIM Vital Nerve Monitoring System and Acquires Ai Biomed

The company also announced further enhancement of its ENT portfolio with the recent acquisition of privately-held Ai Biomed Corp., maker of the PTeye™ parathyroid detection system.

Medtainer, Inc. Completes Acquisition of Advanced Container Technologies

In addition, Medtainer, which is a Florida corporation, changed its name to Advanced Container Technologies, Inc., effective October 3, 2020.

TrialCard Acquires Canary Insights

The company notes this acquisition further strengthens their position as a leading provider of payer intelligence for the biopharmaceutical and medtech industries.

Exxe Group Acquires MMeditech GmbH

Exxe Group reported among other elements, the MMeditech acquisition brings immediate revenues to Exxe, a high level of operating profitability, and a backlog of $2.8 million for 2021.

Medtronic Announces the Planned Acquisition of Avenu Medical

The terms of the transaction were not provided.

Locate Bio Announced the In-licencing of Multiple Late Stage Orthobiologics Assets from RCSI University of Medicine and Health Sciences

The technologies developed by the RCSI Tissue Engineering Research Group have extensive pre-clinical and human data demonstrating their effectiveness in the treatment of both hard and soft tissues.

QIAGEN Fully Acquires NeuMoDx Molecular Rounding Out Portfolio of PCR-Based Diagnostic Automation Systems

September 17, 2020 QIAGEN N.V. today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash....

BioNTech to Acquire GMP Manufacturing Site: To Expand COVID-19 Vaccine Production Capacity in First Half 2021

BioNTech notes the transaction is expected to close in the fourth quarter of 2020. The Company plans to be able to produce up to 250 million doses of BNT162b2 in the first half of 2021.

The Pennant Group Acquires Texas Home Health Agency

Pennant will continue to pursue opportunities for growth in the home health, hospice and senior living industries, targeting strategic and underperforming operations of all sizes.